Study Of Disc Anaesthesia For The Preoperative Diagnosis Of Chronic Lower Back Pain (SODA)
Primary Purpose
Low Back Pain
Status
Completed
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
functional anesthetic discography
provocative discography
Sponsored by
About this trial
This is an interventional diagnostic trial for Low Back Pain focused on measuring low back pain, degenerative disc disease
Eligibility Criteria
Inclusion Criteria:
- Age > 21.
- Chronic axial low back pain without radicular pain for > six months, not responding to at least three months of non-surgical management under the direction of a physician.
- One or two discs at L5/S1, L4/L5 or L3/L4 with abnormal findings by MRI, including any of the following: loss of disc hydration, loss of disc height, high intensity zone (HIZ), Modic changes at adjacent vertebral endplates, or herniation without nerve root compression.
- Subject states that he/she is willing to undergo lumbar spinal fusion, disc replacement, or other definitive treatment if eventual diagnosis supports such treatment.
- Physician believes that discography is clinically indicated for the purpose of surgical decision-making for the subject.
- Pre-treatment low back pain by numerical rating scale (NRS) score > 4 (measured as average in last 24 hours on a 0-10 scale).
- Pre-treatment Oswestry Disability Index (ODI) > 40 (0 - 100 scale).
- Subject states availability for all study visits.
- Subject is able to understand the risks and benefits of participating in the study and provides written informed consent.
Exclusion Criteria:
- Known osteoporosis or osteopenia, metabolic bone disorder, or history of chronic steroid use (the equivalent of 7.5 milligrams of daily prednisone use for > 6 months).
- Suspected painful disc degeneration (based on clinical examination and MRI findings) outside of L5/S1, L4/L5 or L3/L4 levels.
- MRI shows disc abnormalities (listed in Inclusion Criteria #3) at all 3 lower lumbar discs (L3/L4, L4/L5 and L5/S1).
- Abnormal neurologic exam attributable to lumbar disc disease, herniation, or lumbar stenosis.
- Back, buttock or pelvic pain suspected to be due to spinal stenosis, spinal fractures, infection, cancer, facet arthropathy or other hip or pelvis pathology.
- Schmorl's node or endplate disruption evident on MRI at L5/S1, L4/L5, or L3/L4.
- Medical history, physical examination or radiographic evidence (e.g., disc height too narrow) to suggest that either PD or F.A.D. may not be technically feasible.
- Any previous lumbar spine fusion or disc replacement.
- More than grade 1 spondylolisthesis as assessed by x-ray or MRI.
- Significant clinical comorbidity that may potentially interfere with data collection or follow-up (e.g., dementia, severe comorbid illness).
- History of major depression, psychosis or somatization disorder, or panic disorder.
- Allergy to any materials used in PD or F.A.D. devices, contrast, lidocaine, or bupivacaine.
- Any evidence of disc or systemic infection.
- Pregnant or child-bearing potential and not currently on adequate birth control method.
Sites / Locations
- The Spine and Neurosurgery Center
- Spine Source
- Pacific Spine Clinic
- UCSD Orthopaedic Surgery
- Emory Orthopaedics & Spine Center
- Hanover Orthopaedic Associates, Inc.
- Texas Back Institute
- East Texas Medical Center
- Evergreen Surgical Center
- Milwaukee Neurological Institute
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
PD and F.A.D. diagnostic testing
Arm Description
Outcomes
Primary Outcome Measures
Difference in Number of Magnetic Resonance Imaging (MRI)-Positive Discs Diagnosed Positive by Provocative Discography (PD) and Functional Anesthetic Discography (F.A.D.)
For provocative discography (PD), a positive response at an individual disc requires all of the following findings: pain intensity (>=7/10 on 0-10 Numerical Rating Scale, NRS) as rated by subjects on injecting contrast into a disc; concordancy (pain reproduces typical back pain exactly). For Functional Anesthetic Discography (F.A.D.), a positive test at an individual disc level is defined as improvement in self-rated pain of >=2 Numerical Rating Scale (NRS) points AND >33% on 0-10 Numerical Rating Scale 10 minutes after injection of lidocaine.
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT00443781
Brief Title
Study Of Disc Anaesthesia For The Preoperative Diagnosis Of Chronic Lower Back Pain
Acronym
SODA
Official Title
Study Of Disc Anaesthesia For The Preoperative Diagnosis Of Chronic Lower Back Pain
Study Type
Interventional
2. Study Status
Record Verification Date
March 2012
Overall Recruitment Status
Completed
Study Start Date
March 2007 (undefined)
Primary Completion Date
June 2009 (Actual)
Study Completion Date
June 2009 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Medtronic Spine LLC
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The primary objective of this study is to document and compare diagnostic test results and procedure safety in subjects undergoing both Functional Anaesthetic DiscographyTM (F.A.D.) and provocative discography (PD) and determine the appropriateness of the F.A.D. procedure data collection script for use in a larger clinical trial.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Low Back Pain
Keywords
low back pain, degenerative disc disease
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Phase 4
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
62 (Actual)
8. Arms, Groups, and Interventions
Arm Title
PD and F.A.D. diagnostic testing
Arm Type
Other
Intervention Type
Procedure
Intervention Name(s)
functional anesthetic discography
Intervention Description
Functional Anesthetic Discography (F.A.D.) involves the placement and anchoring of a small catheter into a disc. After placement, functional testing is performed, in which the subject elicits his/her back pain via functional maneuvers or postures. Local anaesthetic is then delivered into the target disc through the catheter and the effect on functional back pain is noted.
Intervention Type
Procedure
Intervention Name(s)
provocative discography
Intervention Description
Provocative discography (PD) has been used as a preoperative diagnostic tool for patients with back pain attributed to degenerative disc disease considering lumbar disc surgery. During PD, a clinically suspected disc is accessed with a needle and injected under pressure with radiopaque contrast dye. The subject rates his/her experience of pain for intensity and whether the pain is exactly the same as ("concordant") or different from ("not concordant" or "discordant") typical back pain.
Primary Outcome Measure Information:
Title
Difference in Number of Magnetic Resonance Imaging (MRI)-Positive Discs Diagnosed Positive by Provocative Discography (PD) and Functional Anesthetic Discography (F.A.D.)
Description
For provocative discography (PD), a positive response at an individual disc requires all of the following findings: pain intensity (>=7/10 on 0-10 Numerical Rating Scale, NRS) as rated by subjects on injecting contrast into a disc; concordancy (pain reproduces typical back pain exactly). For Functional Anesthetic Discography (F.A.D.), a positive test at an individual disc level is defined as improvement in self-rated pain of >=2 Numerical Rating Scale (NRS) points AND >33% on 0-10 Numerical Rating Scale 10 minutes after injection of lidocaine.
Time Frame
Approximately 2 hours per subject
10. Eligibility
Sex
All
Minimum Age & Unit of Time
21 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age > 21.
Chronic axial low back pain without radicular pain for > six months, not responding to at least three months of non-surgical management under the direction of a physician.
One or two discs at L5/S1, L4/L5 or L3/L4 with abnormal findings by MRI, including any of the following: loss of disc hydration, loss of disc height, high intensity zone (HIZ), Modic changes at adjacent vertebral endplates, or herniation without nerve root compression.
Subject states that he/she is willing to undergo lumbar spinal fusion, disc replacement, or other definitive treatment if eventual diagnosis supports such treatment.
Physician believes that discography is clinically indicated for the purpose of surgical decision-making for the subject.
Pre-treatment low back pain by numerical rating scale (NRS) score > 4 (measured as average in last 24 hours on a 0-10 scale).
Pre-treatment Oswestry Disability Index (ODI) > 40 (0 - 100 scale).
Subject states availability for all study visits.
Subject is able to understand the risks and benefits of participating in the study and provides written informed consent.
Exclusion Criteria:
Known osteoporosis or osteopenia, metabolic bone disorder, or history of chronic steroid use (the equivalent of 7.5 milligrams of daily prednisone use for > 6 months).
Suspected painful disc degeneration (based on clinical examination and MRI findings) outside of L5/S1, L4/L5 or L3/L4 levels.
MRI shows disc abnormalities (listed in Inclusion Criteria #3) at all 3 lower lumbar discs (L3/L4, L4/L5 and L5/S1).
Abnormal neurologic exam attributable to lumbar disc disease, herniation, or lumbar stenosis.
Back, buttock or pelvic pain suspected to be due to spinal stenosis, spinal fractures, infection, cancer, facet arthropathy or other hip or pelvis pathology.
Schmorl's node or endplate disruption evident on MRI at L5/S1, L4/L5, or L3/L4.
Medical history, physical examination or radiographic evidence (e.g., disc height too narrow) to suggest that either PD or F.A.D. may not be technically feasible.
Any previous lumbar spine fusion or disc replacement.
More than grade 1 spondylolisthesis as assessed by x-ray or MRI.
Significant clinical comorbidity that may potentially interfere with data collection or follow-up (e.g., dementia, severe comorbid illness).
History of major depression, psychosis or somatization disorder, or panic disorder.
Allergy to any materials used in PD or F.A.D. devices, contrast, lidocaine, or bupivacaine.
Any evidence of disc or systemic infection.
Pregnant or child-bearing potential and not currently on adequate birth control method.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ray M Baker, MD
Organizational Affiliation
University of Washington
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Rick D Guyer, MD
Organizational Affiliation
Texas Back Institute, Plano, TX
Official's Role
Principal Investigator
Facility Information:
Facility Name
The Spine and Neurosurgery Center
City
Huntsville
State/Province
Alabama
ZIP/Postal Code
35801
Country
United States
Facility Name
Spine Source
City
Beverly Hills
State/Province
California
ZIP/Postal Code
90212
Country
United States
Facility Name
Pacific Spine Clinic
City
Escondido
State/Province
California
ZIP/Postal Code
92025
Country
United States
Facility Name
UCSD Orthopaedic Surgery
City
San Diego
State/Province
California
ZIP/Postal Code
92103
Country
United States
Facility Name
Emory Orthopaedics & Spine Center
City
Atlanta
State/Province
Georgia
ZIP/Postal Code
30329
Country
United States
Facility Name
Hanover Orthopaedic Associates, Inc.
City
Hanover
State/Province
Pennsylvania
ZIP/Postal Code
17331
Country
United States
Facility Name
Texas Back Institute
City
Plano
State/Province
Texas
ZIP/Postal Code
75093
Country
United States
Facility Name
East Texas Medical Center
City
Tyler
State/Province
Texas
ZIP/Postal Code
75701
Country
United States
Facility Name
Evergreen Surgical Center
City
Kirkland
State/Province
Washington
ZIP/Postal Code
98034
Country
United States
Facility Name
Milwaukee Neurological Institute
City
Milwaukee
State/Province
Wisconsin
ZIP/Postal Code
53233
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Study Of Disc Anaesthesia For The Preoperative Diagnosis Of Chronic Lower Back Pain
We'll reach out to this number within 24 hrs